EDWARDS LIFESCIENCES CORPEDWARDS LIFESCIENCES CORPEDWARDS LIFESCIENCES CORP

EDWARDS LIFESCIENCES CORP

No trades
See on Supercharts

Key facts today

Edwards Lifesciences Corporation reported weak Q2 results on July 24, 2024, and cut its 2024 revenue forecast for the TAVR platform. The stock fell 31.34% to $59.70 per share on July 25, 2024.
Analyze the impactAnalyze the impact
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪831.96 B‬MXN
136.87MXN
‪23.82 B‬MXN
‪101.99 B‬MXN
‪579.76 M‬
Beta (1Y)
1.25
Employees (FY)
‪19.8 K‬
Change (1Y)
‪+2.5 K‬ +14.45%
Revenue / Employee (1Y)
‪303.27 K‬MXN
Net income / Employee (1Y)
‪70.83 K‬MXN

About Edwards Lifesciences Corporation


CEO
Bernard J. Zovighian
Headquarters
Irvine
Founded
1958
FIGI
BBG00HZQRZH1
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of EW is 1,406.00 MXN — it has increased by 7.45% in the past 24 hours. Watch EDWARDS LIFESCIENCES CORP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange EDWARDS LIFESCIENCES CORP stocks are traded under the ticker EW.
EW stock has risen by 7.45% compared to the previous week, the month change is a 4.93% rise, over the last year EDWARDS LIFESCIENCES CORP has showed a 22.09% increase.
We've gathered analysts' opinions on EDWARDS LIFESCIENCES CORP future price: according to them, EW price has a max estimate of 1,825.59 MXN and a min estimate of 1,277.92 MXN. Watch EW chart and read a more detailed EDWARDS LIFESCIENCES CORP stock forecast: see what analysts think of EDWARDS LIFESCIENCES CORP and suggest that you do with its stocks.
EW reached its all-time high on Apr 21, 2022 with the price of 2,606.47 MXN, and its all-time low was 767.63 MXN and was reached on Feb 1, 2018. View more price dynamics on EW chart.
See other stocks reaching their highest and lowest prices.
EW stock is 6.93% volatile and has beta coefficient of 1.25. Track EDWARDS LIFESCIENCES CORP stock price on the chart and check out the list of the most volatile stocks — is EDWARDS LIFESCIENCES CORP there?
Today EDWARDS LIFESCIENCES CORP has the market capitalization of ‪831.96 B‬, it has increased by 4.13% over the last week.
Yes, you can track EDWARDS LIFESCIENCES CORP financials in yearly and quarterly reports right on TradingView.
EDWARDS LIFESCIENCES CORP is going to release the next earnings report on Jan 30, 2025. Keep track of upcoming events with our Earnings Calendar.
EW earnings for the last quarter are 13.20 MXN per share, whereas the estimation was 13.09 MXN resulting in a 0.81% surprise. The estimated earnings for the next quarter are 11.25 MXN per share. See more details about EDWARDS LIFESCIENCES CORP earnings.
EDWARDS LIFESCIENCES CORP revenue for the last quarter amounts to ‪26.69 B‬ MXN, despite the estimated figure of ‪30.43 B‬ MXN. In the next quarter, revenue is expected to reach ‪27.69 B‬ MXN.
EW net income for the last quarter is ‪60.51 B‬ MXN, while the quarter before that showed ‪6.72 B‬ MXN of net income which accounts for 800.57% change. Track more EDWARDS LIFESCIENCES CORP financial stats to get the full picture.
No, EW doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has ‪19.80 K‬ employees. See our rating of the largest employees — is EDWARDS LIFESCIENCES CORP on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EDWARDS LIFESCIENCES CORP EBITDA is ‪34.44 B‬ MXN, and current EBITDA margin is 30.22%. See more stats in EDWARDS LIFESCIENCES CORP financial statements.
Like other stocks, EW shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EDWARDS LIFESCIENCES CORP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EDWARDS LIFESCIENCES CORP technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EDWARDS LIFESCIENCES CORP stock shows the neutral signal. See more of EDWARDS LIFESCIENCES CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.